News
First Investment: 2020
The bacteria in our guts break down indigestible materials and excrete essential nutrients. Novome makes these microbes even more useful by modifying them to manufacture therapeutic proteins, under the control of simple on-off switches in the form of sugar pills.
News & Insights
Explore Companies
DVLP Medicines
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing
Noetik
Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer
Solu Therapeutics
Advancing precision medicine by combining the efficacy of antibodies with the binding ability of small molecules
Visolis
Using synthetic biology to manufacture carbon-negative materials